Pepper

Pepper (Piper nigrum L.): A Comprehensive Reference Article

1. Identity

Botanical and Chemical Names

Black pepper (Piper nigrum L.) belongs to the family Piperaceae and is used as a spice in both modern and traditional cooking. It is also known as the "King of Spices." P. nigrum is native to Kerala in Southwestern India and is widely distributed in tropical regions, including Indonesia. Piper nigrum is a perennial vine that can reach heights of 10 meters or more if left unchecked, with dark green, heart-shaped leaves and small white flowers. The berries grow in clusters, starting off green before ripening into red, and once dried, they shrivel into the black, wrinkled peppercorns familiar worldwide.

The pungency of black pepper is due to the interaction of its major compound, piperine (chemical name: 1-piperoyl-piperidine), with the human TRPV-1 (vanilloid) receptor. Piperine is one of the major alkaloids isolated from black pepper and also occurs in the ripe fruits of Piper longum L. and the roots of Piper sarmentosum Roxb.

The piperine content of black pepper fruit has been reported as ranging from 1.7–7.4% in Piper nigrum fruit, and from 5–9% in Piper longum spike and root. The average piperine content in pepper is commonly assumed to be 6% by dry weight, and the daily consumption of pepper ranges from approximately 83 to 333 mg; consequently, doses of 5 to 20 mg of piperine are often administered daily in clinical trials.

Forms and Preparations

Black pepper is made from the plant's unripened green drupes (stone fruit), called "peppercorns," which are briefly boiled and dried or cooked. The same plant source yields several distinct commercial and culinary forms:

• Black pepper: Harvested unripe and dried, retaining the outer pericarp. The pericarp contributes aroma-active terpenes and results in the highest polyphenol content among the three main pepper types.
• White pepper: White pepper is stripped of the fruit layer, which means the aroma-contributing terpenes found in the pericarp are largely absent. White pepper can gain different odors (including musty notes) from its longer fermentation stage.
• Green pepper: The qualitative and quantitative composition of the essential oil differs between black, green, and white pepper, reflecting different ripening states.

In supplement and nutraceutical contexts, pepper is most commonly encountered as standardized piperine extract (commonly standardized to 95% piperine, commercially trademarked as BioPerine®), black pepper essential oil, and oleoresin. In white pepper, β-caryophyllene is the primary component of the essential oils, while piperine is present in the oleoresin.

2. Traditional and Historical Use

India — Ayurvedic and Siddha Medicine

Native to southern and southeast Asia, black pepper's use in Indian cooking dates to the first century BC. In ancient India, black pepper (Maricha in Sanskrit) wasn't just a kitchen staple — it was revered in religious ceremonies and traditional healing. In Ayurvedic practice, black pepper's medicinal use is documented in classical texts like the Charaka Samhita and the Sushruta Samhita, where it is praised for treating respiratory disorders, digestive issues, and even as a rejuvenative when combined with honey.

Due to its prominent status within the Ayurvedic system of medicine, black pepper has been historically incorporated as a constituent of the "Trikatu" formulation, along with long pepper (Piper longum) and ginger. In Ayurveda, it serves as a digestive stimulant and a component of Trikatu, and in Rasashastra (Ayurvedic alchemy) it was used in medicinal pill preparation.

As a major constituent in several Siddha drugs, black pepper has a significant role in the traditional Indian system of medicine. Classical Siddha preparations that contain black pepper as a medicine include amukkara choornam, Nilavembu kudineer, and Trikaduku choornam. Black pepper (filfil siyah) is also an integral part of the Unani system of medicine, where it is used to treat various ailments.

Traditional Chinese Medicine

P. nigrum is a traditional dual-use resource of medicine and food in China, where it has traditionally been used for treating chills, stomach complaints, detoxification, and rheumatism. Pepper has been used for the treatment of epilepsy since the Tang Dynasty in China.

Ancient Greece, Rome, and Medieval Europe

Black pepper became popular across Europe during the Roman Empire, and in ancient Greece it was so valued that it was used as currency. Black pepper was one of the most sought-after commodities during the spice trade era, from around 1,000 BCE to 1,000 CE, and was worth its weight in gold. The spice routes, which connected the East and the West, were established primarily to facilitate the trade of black pepper and other spices.

Traditional Preparations and Purposes Across Cultures

Across traditional systems, black pepper has been used for the treatment of various diseases including cough, cold, dyspnea, throat diseases, intermittent fever, dysentery, stomachache, worms, and piles. As a folk medicine, P. nigrum has also been used to treat gastrointestinal disorders, rheumatism, flu, colds, muscular aches, and fever.

3. Key Constituents and Active Compounds

Alkaloids

The major bioactive compound identified in P. nigrum is piperine, although other compounds are also present including piperic acid, piperlonguminine, pellitorine, piperolein B, piperamide, piperettine, and (−)-kusunokinin, which also showed biological potency. Other alkaloids present in black pepper extracts include piperanine, piperettine, piperylin A, piperolein B, and pipericine. Piperine naturally exists in four isomeric forms, though only the piperine isomers have pungency and biological activity compared to the other three.

Essential Oil / Terpene Constituents

The most abundant compounds in pepper essential oils are (E)-β-caryophyllene (1.4–70.4%), limonene (2.9–38.4%), β-pinene (0.7–25.6%), δ-3-carene (1.7–19.0%), sabinene (0–12.2%), α-pinene (0.3–10.4%), eugenol (0.1–41.0%), terpinen-4-ol (0–13.2%), hedycaryol (0–9.1%), β-eudesmol (0–9.7%), and caryophyllene oxide (0.1–7.2%). Black pepper oil is basically composed of terpenes, the primary ones being β-caryophyllene, limonene, δ-3-carene, and pinene.

Analysis of cold-pressed black pepper oil revealed the presence of the lignan sesamin (39.78%), the alkaloid piperine (33.79%), the monoterpene hydrocarbons 3-carene (9.53%) and limonene (6.23%), and the sesquiterpene β-caryophyllene (10.67%). The composition can vary depending on both the extraction method used and the maturity of the fruit at harvest.

Other Phytochemicals

Phytochemical analyses have described the main chemical constituents of black pepper as including carbohydrates, proteins, calcium, magnesium, potassium, iron, vitamin C, tannins, flavonoids, and carotenoids. P. nigrum consists of diverse bioactive compounds, such as sterols, fatty acids, terpenes, amides, and other phytoconstituents with a variety of biological activities.

4. Mechanisms of Action

TRPV1 (Vanilloid Receptor) Activation

The perception of pungency from piperine arises from the stimulation of transient receptor potential cation channels for vanilloid (TRPV1). This mechanism is shared with capsaicin from chili peppers but is structurally distinct; piperine is considerably less potent at this receptor on a weight-for-weight basis.

Inhibition of Drug-Metabolizing Enzymes and Transporters

Piperine is a known inhibitor of glucuronidation in the liver and intestine. The bioavailability enhancement of drugs by piperine has been attributed to piperine-mediated inhibition of the CYP3A4 enzyme. Piperine also has inhibitory potency at CYP2C9, CYP2E1, and CYP3A4 substrates. Additionally, piperine enhances the ultrastructure of intestinal microvilli, increasing nutrient absorption in the gastrointestinal system.

Anti-Inflammatory Signaling

In cell-based (in vitro) research using LPS-stimulated macrophages, piperine at 10–20 mg/L attenuated the production of NO and ROS, downregulated the protein and mRNA expression levels of TNF-α, IL-1β, and IL-6, and upregulated IL-10. Piperine was shown to inhibit the phosphorylation levels of ERK, JNK, p38, and p65 proteins, suggesting its molecular mechanism involves regulation of key factors of the NF-κB and MAPK signalling pathways.

Anticancer Pathways

Piperine exerts anticancer effects through inhibition of the PI3K/Akt/mTOR and ERK1/2 pathways, activation of p38 and JNK pathways, and suppression of NF-κB/AP-1 signaling. Piperine also disrupts Wnt/β-catenin signaling by inhibiting β-catenin nuclear translocation and TCF binding, thereby impairing cancer cell growth and metastasis. The mechanisms involve G₀ and G₂/M arrest of the cell cycle, mitochondria-mediated apoptosis (involving Bax/Bcl-2 modulation and caspase activation), and cancer cell death.

Antioxidant Mechanisms

Piperine, the primary bioactive compound found in black pepper, exhibits various functional properties, including antioxidant, antimicrobial, anti-inflammatory, and anticancer activities. In vitro and in vivo data have provided deep insight into the mechanisms of piperine's antioxidant and anti-inflammatory efficacy, together with its ability to interfere with several molecular signaling pathways.

5. Scientific Evidence by Area of Use

5.1 Bioavailability Enhancement

The most robustly studied function of piperine in humans is its role as a bioenhancer. In a clinical study, 2 g of curcumin administered concomitantly with 20 mg of piperine appeared to promote a significant 2000% increase in the oral bioavailability of curcumin. This effect of piperine on the pharmacokinetics of curcumin has been shown to be much greater in humans than in rats. In humans, curcumin bioavailability was increased by 2,000% at 45 minutes after co-administering curcumin orally with piperine, whereas in rats, concomitant administration of piperine 20 mg/kg with curcumin 2 g/kg increased serum concentration by 154%. The study shows that in the dosages used, piperine enhances the serum concentration, extent of absorption, and bioavailability of curcumin in both rats and humans with no adverse effects.

However, this frequently cited finding has important limitations. There is a lack of any further studies providing direct evidence of piperine enhancing the bioavailability of curcumin in humans. A review by Mimica et al. (2022) found that although piperine was used in a substantial number of curcumin clinical studies, there was no comparison of its effect on bioavailability, and most studies rely on the findings of Shoba et al. (1998). A more recent pharmacokinetic study found that piperine addition provided no benefit and underscored that bioavailability claims should be based on unconjugated curcumin and not on its poorly membrane-permeable conjugates.

Piperine has demonstrated broader bioenhancer activity with other compounds. A dose of 20 mg/day of piperine administered for 10 consecutive days increased the AUC of carbamazepine by 47% compared to carbamazepine alone in healthy volunteers. Pretreatment with piperine at 15 mg/day for three consecutive days elevated the AUC of midazolam by 20% when compared to midazolam administered without piperine in healthy subjects. Additionally, piperine is a bioavailability enhancer that can increase bioavailability when used in combination with rifampicin, phenytoin sodium, and verapamil, by preventing drug efflux from cells or reducing the metabolism of drugs.

Evidence strength: The bioenhancer effect at the pharmacokinetic level in humans is supported by multiple clinical pharmacology studies, though the magnitude and clinical significance varies by the co-administered agent. For curcumin, the most cited human study remains preliminary and has not been adequately replicated with modern bioavailability assessment methods.

5.2 Metabolic Health: Lipids, Glycaemia, and Obesity

A review of clinical evidence summarized findings supporting the beneficial effects of black pepper (Piper nigrum L.), including its active ingredient piperine, in improving blood lipid profiles — specifically reducing circulating levels of total cholesterol, LDL cholesterol, and triglycerides in overweight and obese individuals. The intake of piperine was also linked with enhanced antioxidant and anti-inflammatory properties by increasing serum levels of superoxide dismutase while reducing those of malonaldehyde and C-reactive protein in individuals with metabolic syndrome.

The antidiabetic property of black pepper has been confirmed in vivo, as well as hypolipidemic activity evidenced by decreases in cholesterol, triglycerides, and LDL, and increases in HDL. However, this animal-level evidence must be distinguished from human clinical data. In human studies, piperine has demonstrated a variety of pharmacological effects, including anti-hyperlipidemic and anti-diabetic activities.

Regarding thermogenesis and weight management, human evidence is notably weak. After receiving a single brunch meal containing 1.3 g of pepper, there was no statistical significance related to postprandial diet-induced thermogenesis, as well as in appetite or food intake in young male participants. Investigation of the impact of 0.5 g of black pepper as part of a meal on 24-hour energy expenditure, respiratory quotient, and biochemical markers of metabolism and satiety showed a lack of effect on energy expenditure in overweight post-menopausal women.

Evidence strength: Preclinical evidence for lipid-lowering and antidiabetic effects is substantial. Limited human clinical data exist for lipid effects in metabolic syndrome populations. Human evidence for thermogenesis and weight loss via piperine alone is currently negative or neutral.

5.3 Gastrointestinal and Digestive Health

Key alkaloid components of Piper nigrum, particularly piperine, assist in cognitive brain functioning, boost nutrient absorption, and improve gastrointestinal functionality. Piperine acts as a bioenhancer by improving the ultrastructure of intestinal microvilli and increasing nutrient absorption in the gastrointestinal system.

Preclinical evidence has shown that administration of piperine at a dose of 50 mg/kg could improve the digestive system while reducing oxidative stress and inflammation in mice. Emerging clinical evidence also indicates that pepper may be beneficial in alleviating complications linked with other chronic conditions, including digestion and oropharyngeal dysphagia.

Evidence strength: Preclinical (animal/in vitro) evidence for gastroprotective and digestive effects is moderate. Direct human clinical evidence specifically for digestive endpoints using pepper or isolated piperine remains limited and preliminary.

5.4 Antioxidant and Anti-Inflammatory Effects

Piperine contains various bioactive effects, including antibacterial activity, and several physiological benefits that could help overall human health, such as immunomodulatory, hepatoprotective, antioxidant, and antimetastatic properties. Piper nigrum also has demonstrated anti-inflammatory, analgesic, anticonvulsant, and neuroprotective effects, though much of this evidence comes from preclinical studies.

In a clinical context involving inflammatory bowel disease, a randomized, double-blind trial enrolled patients with Crohn's disease or ulcerative colitis, who were randomly assigned to placebo, curcumin (1000 mg/day), or curcumin plus piperine (1000 mg + 10 mg/day) for 12 weeks. The combination of curcumin and piperine has shown successful outcomes in diseases where oxidative stress is a significant etiological factor, such as metabolic syndrome.

Evidence strength: Anti-inflammatory and antioxidant effects are extensively characterized at the in vitro and animal level, with defined molecular targets (NF-κB, MAPK pathways). Human clinical evidence for standalone anti-inflammatory effects of piperine is still limited and often confounded by co-administration with other bioactive compounds.

5.5 Neuroprotection and Cognitive Function

The neuroprotective properties of piperine, the major alkaloid extracted from black pepper, have been under investigation, though its mechanism of action in excitotoxicity is still poorly understood. Piperine has been found to provide neural protective actions in various in vitro and in vivo experimental models.

In human studies, the evidence is negative thus far for acute cognitive enhancement. A single dose of black pepper capsules (2.0 g) showed a lack of activity on short-term improvements in sustained attention, motivation to perform cognitive tasks, or feelings of mental energy and fatigue in young adults with low energy.

Evidence strength: Neuroprotective effects of piperine are demonstrated in animal models, with proposed mechanisms including antioxidant activity and NGF (nerve growth factor) signalling modulation. Human clinical evidence is currently insufficient to support cognitive enhancement claims.

5.6 Anticancer Properties

Piper nigrum has exhibited anticancer effects against a number of cell lines from breast, colon, cervical, and prostate cancers through different mechanisms including cytotoxicity, apoptosis, autophagy, and interference with signaling pathways. Its antitumor potential, demonstrated through its apoptotic effect on many cancer types, should be further investigated, especially in the form of human clinical trials, since such data do not currently exist.

Evidence strength: All current anticancer evidence for piperine is derived from in vitro cell line studies and in vivo animal models. No human clinical trials have evaluated piperine as a standalone anticancer agent.

5.7 Tuberculosis — Adjunct Therapy

Piperine has been evaluated in clinical trials as an adjunct to standard anti-tuberculosis regimens. In clinical trial data, a treatment group receiving a piperine-containing regimen showed a higher sputum conversion rate (93%) versus a control group (84%) at 4 weeks, and a higher cure rate at the end of 24 weeks (92%) versus the control group (82%), along with decreased side effects (3 patients versus 9 patients in the control group). This likely reflects piperine's bioenhancer role in improving the pharmacokinetics of rifampicin and isoniazid.

Evidence strength: Preliminary positive clinical data exist, primarily attributed to the bioavailability-enhancing effect of piperine on anti-tuberculosis drugs rather than a direct antimicrobial effect.

6. Body Systems and Health Areas

• Gastrointestinal system: Digestive stimulant, gastric acid secretion, gastroprotection, gut motility.
• Metabolic system: Lipid profile modulation, blood glucose regulation, thermogenesis (evidence mixed/negative in humans).
• Immune system: Immunomodulatory properties have been established for piperine.
• Cardiovascular system: Through lipid-lowering and anti-inflammatory effects.
• Nervous system: Piperine has antioxidant, anti-inflammatory, and antitumour effects; it has also been found to provide neural protective actions in various in vitro and in vivo experimental models.
• Respiratory system: Anti-asthmatic activities have been reported in human studies of piperine.
• Musculoskeletal system: Preclinical models show piperine can reduce complications of arthritis.
• Pharmacokinetic system: Modulation of drug-metabolizing enzymes (CYP3A4, CYP2C9, CYP2E1) and efflux transporters (P-glycoprotein).

7. Dosage Forms and Reported Doses

Black pepper and its principal constituent piperine are available in several forms:

• Whole or ground peppercorns: Used in culinary preparations. The daily consumption of pepper in dietary contexts ranges from approximately 83 to 333 mg of whole pepper.
• Standardized piperine extract: Doses of 5 to 20 mg of piperine are often administered daily in clinical trials.
• Bioavailability enhancement (curcumin): In the most cited clinical study, 20 mg of piperine was used concomitantly with 2 g of curcumin.
• Drug pharmacokinetic interaction studies: A dose of 20 mg/day of piperine administered for 10 consecutive days was used in carbamazepine interaction studies in healthy volunteers. Pretreatment with piperine at 15 mg/day for three consecutive days was used in midazolam interaction studies.
• IBD clinical trial (curcumin + piperine): Participants were assigned curcumin plus piperine at 1000 mg + 10 mg/day for 12 weeks.
• Black pepper essential oil: Distilled from the unripe dried fruit for aromatherapy and topical formulation use, standardized to terpene content.

8. Safety Considerations and Drug Interactions

Drug Interactions via CYP450 and P-glycoprotein Inhibition

Clinical studies suggest that piperine (usually in doses of 20 mg/day) can inhibit CYP3A4, CYP2C9, and P-glycoprotein (PGP), resulting in moderate increases in plasma concentrations of CYP3A4 substrates (carbamazepine, midazolam, and possibly others), CYP2C9 substrates (diclofenac, phenytoin, and possibly warfarin and others), and PGP substrates (fexofenadine and possibly digoxin and others).

In one study, 12 healthy subjects took a single 120-mg dose of fexofenadine before and after administration of piperine 20 mg/d for 10 days; with piperine pretreatment, fexofenadine AUC increased by 68%, though fexofenadine half-life was not significantly affected. Previous evidence from in vitro and animal studies does suggest that piperine inhibits P-glycoprotein (PGP), but more clinical evidence is needed to determine if piperine interacts with other PGP substrates with a greater risk of toxicity, such as digoxin. The possibility of PGP inhibition by piperine also raises the issue of piperine simultaneously inhibiting PGP and CYP3A4.

Piperine is found in a number of herbal products, but it is not clear whether dietary use of black pepper in normal culinary quantities would result in clinically significant drug interactions.

Reproductive and Developmental Toxicity Signals (Animal Data)

Animal studies with higher daily piperine bolus doses than used in human interaction studies provide indications of disturbance of spermatogenesis and of maternal reproductive and embryotoxic effects. Although the available human studies rarely reported effects that were regarded as being adverse, their suitability for detailed risk assessment is limited due to an insufficient focus on safety parameters apart from drug interactions, as well as due to the lack of investigation of the potentially adverse effects observed in animal studies.

Glucuronidation Inhibition and Toxin Metabolism

One concern with piperine's mechanism of action is that it inhibits glucuronidation, which is a process that is protective against many toxins and is also involved in the metabolism of commonly used drugs; inhibiting this process carries a theoretical risk of unintended interactions.

General Tolerability

In human and animal studies with single or short-term bolus application of isolated piperine, interactions with several drugs — in most cases resulting in increased drug bioavailability — were observed. Depending on the drug and extent of the interaction, such interactions may carry the risk of unintended, deleteriously increased, or adverse drug effects. Preliminary evidence suggests that piperine also increases serum concentrations of chlorzoxazone, propranolol, and theophylline.

References

• Umapathy et al. (2024). Anticancer Potential of the Principal Constituent of Piper nigrum, Piperine: A Comprehensive Review. PMC / Cureus.
• Damanhouri & Ahmad (2014 / 2019). A systematic review on black pepper (Piper nigrum L.): from folk uses to pharmacological applications. PubMed.
• Meghwal & Goswami (2021). Phytochemistry and therapeutic potential of black pepper [Piper nigrum (L.)] essential oil and piperine: a review. Clinical Phytoscience.
• Schnabel et al. (2021). Identification and characterization of piperine synthase from black pepper, Piper nigrum L. PMC / Communications Biology.
• ScienceDirect Topics: Piper Nigrum — Overview.
• Tiwari et al. (2020). Piperine: A comprehensive review of methods of isolation, purification, and biological properties. ScienceDirect / Pharmacological Research.
• Liu et al. (2023). Piperine: Chemistry and Biology. PMC / Toxins.
• Oves et al. (2019). Biological Activities and Chemical Constituents of Essential Oils from Piper cubeba Bojer and Piper nigrum L. PMC.
• Stohs et al. (2024). Enhancing the Bioavailability and Bioactivity of Curcumin for Disease Prevention and Treatment. MDPI Antioxidants.
• Njike et al. (2023). Bioactive Properties, Bioavailability Profiles, and Clinical Evidence of the Potential Benefits of Black Pepper (Piper nigrum) and Red Pepper (Capsicum annum) against Diverse Metabolic Complications. PMC / Nutrients.
• Butt et al. (2013). Black pepper and health claims: a comprehensive treatise. PubMed / Critical Reviews in Food Science and Nutrition.
• Meghwal & Goswami (2019). Piperine — A Major Principle of Black Pepper: A Review of Its Bioactivity and Studies. MDPI Applied Sciences.
• Beserra et al. (2024). Effect of Curcumin Plus Piperine on Redox Imbalance, Fecal Calprotectin and Cytokine Levels in Inflammatory Bowel Disease Patients: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. PMC.
• Wang et al. (2024). Predicting Food–Drug Interactions between Piperine and CYP3A4 Substrate Drugs Using PBPK Modeling. PMC / MDPI.
• Meghwal & Bhaskar (2022). Molecular and pharmacological aspects of piperine as a potential molecule for disease prevention and management: evidence from clinical trials. PMC / Biomedicine & Pharmacotherapy.
• Piperine Drug Interactions. Pharmacy Times.
• Burapan et al. (2021). Safety Aspects of the Use of Isolated Piperine Ingested as a Bolus. PMC.
• Jirovetz et al. (2004). Effect of storage on the essential oil composition of Piper nigrum L. fruits of different ripening states. PubMed / Journal of Agricultural and Food Chemistry.
• Moldovan et al. (2021). Neuroprotective Effects of Black Pepper Cold-Pressed Oil on Scopolamine-Induced Oxidative Stress and Memory Impairment in Rats. PMC.
• Zhang et al. (2022). Piperine Derived from Piper nigrum L. Inhibits LPS-Induced Inflammatory through the MAPK and NF-κB Signalling Pathways in RAW264.7 Cells. PMC.
• Rashid et al. (2025). Piperine and its nanoformulations: A mechanistic review of their anti-cancer activities. ScienceDirect / Biomedicine & Pharmacotherapy.
• Manayi et al. (2021). Overview of the Anticancer Potential of the "King of Spices" Piper nigrum and Its Main Constituent Piperine. PMC.
• Ferruzzi et al. (2025). A pharmacokinetic study and critical reappraisal of curcumin formulations enhancing bioavailability. ScienceDirect / iScience.
• Pham et al. (2025). Essential Oils From Different Parts of Piper nigrum L.: Chemical Composition, Antibacterial, and Antioxidant Activities. PMC.
• Gu et al. (2022). Piperine Provides Neuroprotection against Kainic Acid-Induced Neurotoxicity via Maintaining NGF Signalling Pathway. PMC.
• Lindheimer et al. (2025). Bioenhancer Assessment of Black Pepper with Turmeric on Self-Reported Pain Ratings in Adults: A Randomized, Cross-Over, Clinical Trial. PMC.
• Banji et al. (2014). Piperine, a Natural Bioenhancer, Nullifies the Antidiabetic and Antioxidant Activities of Curcumin in Streptozotocin-Diabetic Rats. PMC / PLOS ONE.
• Committee on Toxicity (UK). Turmeric and Curcumin Supplements — Toxicokinetics.